Heilman, Raymond L <br/><br/>
Delayed allograft inflammation following alemtuzumab induction for kidney transplantation.  [electronic resource] 

 -  Clinical transplantation   
 - 772-80 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1399-0012 
<br/><br/><label>Standard No.: </label>10.1111/ctr.12201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alemtuzumab<br/>Allografts<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antilymphocyte Serum--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Case-Control Studies<br/>Delayed Graft Function--diagnosis<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate<br/>Graft Rejection--diagnosis<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Inflammation--diagnosis<br/>Kidney Failure, Chronic--complications<br/>Kidney Function Tests<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Prognosis<br/>Risk Factors<br/>T-Lymphocytes--immunology<br/>Tacrolimus--therapeutic use